Medifast, Inc.
MED
$12.36
$0.534.48%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 429.70M | 480.45M | 543.45M | 602.46M | 674.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 429.70M | 480.45M | 543.45M | 602.46M | 674.48M |
| Cost of Revenue | 118.43M | 125.67M | 141.88M | 157.84M | 176.70M |
| Gross Profit | 311.27M | 354.78M | 401.58M | 444.62M | 497.77M |
| SG&A Expenses | 312.47M | 349.80M | 403.40M | 437.24M | 482.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 435.40M | 479.96M | 549.78M | 599.58M | 663.63M |
| Operating Income | -5.70M | 487.00K | -6.32M | 2.88M | 10.85M |
| Income Before Tax | 2.02M | 6.25M | -7.27M | 3.79M | 12.32M |
| Income Tax Expenses | 1.77M | 2.62M | -275.00K | 1.70M | 4.99M |
| Earnings from Continuing Operations | 0.25 | 3.64 | -7.00 | 2.09 | 7.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 248.00K | 3.64M | -7.00M | 2.09M | 7.33M |
| EBIT | -5.70M | 487.00K | -6.32M | 2.88M | 10.85M |
| EBITDA | 17.45M | 23.38M | 15.59M | 24.78M | 23.72M |
| EPS Basic | 0.02 | 0.33 | -0.64 | 0.19 | 0.67 |
| Normalized Basic EPS | 0.12 | 0.36 | -0.42 | 0.22 | 0.71 |
| EPS Diluted | 0.01 | 0.32 | -0.65 | 0.18 | 0.66 |
| Normalized Diluted EPS | 0.11 | 0.36 | -0.42 | 0.21 | 0.70 |
| Average Basic Shares Outstanding | 43.87M | 43.81M | 43.76M | 43.72M | 43.68M |
| Average Diluted Shares Outstanding | 43.98M | 43.96M | 43.84M | 43.85M | 43.80M |
| Dividend Per Share | -- | -- | -- | -- | 0.00 |
| Payout Ratio | 78.63% | 5.39% | -2.84% | 34.18% | 255.16% |